Taxonomy Code 1835X0200X(1835x0200x)
Oncology Pharmacist. Providers: 21
Oncology Pharmacist Providers
| NPI | Name | Type | Address |
|---|---|---|---|
|
DR. PHARM.D. Robert S Mancini |
Individual |
100 E Idaho St Boise, ID |
|
|
DR. PHARM.D., BCOP Stephanie Magdanz |
Individual |
500 W Fort St Boise, ID |
|
|
Julia R Kerr |
Individual |
100 E Idaho St Ste 300 Boise, ID |
|
|
Bryce Benson |
Individual |
100 E Idaho St Boise, ID |
|
|
PHARMD Weiyi Li |
Individual |
100 E Idaho St Ste 300 Boise, ID |
|
|
RPH James William Byron |
Individual |
190 E Bannock St Boise, ID |
|
|
R.PH. David Blair Wilson |
Individual |
100 E Idaho St Boise, ID |
|
|
PHARMD Stephanie Matta |
Individual |
100 E Idaho St Boise, ID |
|
|
PHARMD Jessie Modlin |
Individual |
100 E Idaho St Boise, ID |
|
|
PHARMD Leslie Lynn Lamontagne |
Individual |
100 E Idaho St Boise, ID |
|
|
Lauren Zupsic |
Individual |
100 E Idaho St Boise, ID |
|
|
DR. PHARMD Amanda Lorene Wright |
Individual |
190 E Bannock St Boise, ID |
|
|
DR. PHARMD Sarah Rosemarie Hogue |
Individual |
100 E Idaho St Boise, ID |
|
|
PHARMD Christina Gullion |
Individual |
100 E Idaho St Boise, ID |
|
|
DR. PHARMD Allison Reed |
Individual |
100 E Idaho St Boise, ID |
|
|
PHARMD Mckay Herpel |
Individual |
100 E Idaho St Boise, ID |
|
|
DR. PHARMD Lindsey Catlin |
Individual |
100 E Idaho St Boise, ID |
|
|
PHARMD Meagan T Wakefield |
Individual |
100 E Idaho St Boise, ID |
|
|
PHARMD, BCIDP Krystal Shockey |
Individual |
190 E Bannock St Boise, ID |
|
|
DR. PHARMD Jianne Castelo De Raya |
Individual |
100 E Idaho St Boise, ID |
How to obtain, renew, or terminate an NPI
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
| Taxonomy Code | 1835X0200X |
| Specialization | Oncology |
| Display Name | Oncology Pharmacist |
| Taxonomy Group | Pharmacy Service Providers |
| Taxonomy Classification | Pharmacist |
| Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
| Effective Date | September 30, 2009 |